Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 3/20 | 0.41 |
| ▸ | DPP4 | P27487 | 6/20 | 0.40 |
| ▸ | DPP8 | Q6V1X1 | 4/20 | 0.40 |
| ▸ | DPP9 | Q86TI2 | 4/20 | 0.40 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.40 |
| ▸ | ENPEP | Q07075 | 4/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CCR1 | P32246 | 1/20 | 0.33 |
| ▸ | FAP | Q12884 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4050837 | 0.91 | DPP4 (0.44) | CTSKDPP4DPP8DPP9DPP7 | |
| SCHEMBL4054797 | 0.88 | CTSK (0.46) | CTSKDPP4DPP8DPP9DPP7 | |
| SCHEMBL4047638 | 0.86 | CTSK (0.44) | CTSKDPP4DPP8DPP9DPP7 | |
| SCHEMBL4047119 | 0.85 | CTSK (0.52) | CTSKDPP4DPP8DPP9DPP7 | |
| SCHEMBL4045132 | 0.85 | DPP4 (0.51) | CTSKDPP4DPP8DPP9DPP7 | |
| SCHEMBL4052757 | 0.85 | DPP4 (0.48) | CTSKDPP4DPP8DPP9DPP7 | |
| SCHEMBL4049054 | 0.85 | DPP4 (0.52) | CTSKDPP4DPP8DPP9DPP7 | |
| SCHEMBL4046821 | 0.84 | DPP4 (0.44) | CTSKDPP4DPP8DPP9DPP7 | |
| SCHEMBL4040442 | 0.84 | CTSK (0.45) | CTSKDPP4DPP8DPP9DPP7 | |
| SCHEMBL4046608 | 0.83 | CTSK (0.45) | CTSKDPP4DPP8DPP9DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1546150-B1 | PYRROLE DERIVATIVES AS INHIBITORS OF CYTEINE PROTEASES | AMURA THERAPEUTICS LTD (GB) | 2009-03-04 | — | — | EP | claimed |